These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37860682)

  • 1. Percutaneous mitral and tricuspid edge-to-edge repair as a bridge therapy to heart transplantation in advanced heart failure secondary to human immunodeficiency virus: a case report.
    Aquino-Bruno H; Andrade-Cuellar EN; Morales-Portano JD; Alcántara-Meléndez MA
    Eur Heart J Case Rep; 2023 Oct; 7(10):ytad488. PubMed ID: 37860682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantation.
    Geis NA; Pleger ST; Bekeredjian R; Chorianopoulos E; Kreusser MM; Frankenstein L; Ruhparwar A; Katus HA; Raake PWJ
    ESC Heart Fail; 2018 Oct; 5(5):892-901. PubMed ID: 30058757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edge-to-edge tricuspid valve repair for severe tricuspid regurgitation 20 years after cardiac transplantation.
    Misumida N; Steidley DE; Eleid MF
    ESC Heart Fail; 2020 Dec; 7(6):4320-4325. PubMed ID: 32945151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Mind the Gap": An 85-Year-Old Man with Severe Tricuspid Valve Regurgitation Who Underwent Percutaneous Edge-to-Edge Valve Leaflet Plication Using the New and Advanced MitraClip XTR System.
    Mueller KAL; Jorbenadze R; Gawaz M; Schreieck J; Seizer P
    Am J Case Rep; 2021 Jan; 22():e928089. PubMed ID: 33456048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure.
    Orban M; Rommel KP; Ho EC; Unterhuber M; Pozzoli A; Connelly KA; Deseive S; Besler C; Ong G; Braun D; Edwards J; Miura M; Gülmez G; Stolz L; Gavazzoni M; Zuber M; Orban M; Nabauer M; Maisano F; Thiele H; Massberg S; Taramasso M; Fam NP; Lurz P; Hausleiter J
    JACC Heart Fail; 2020 Apr; 8(4):265-276. PubMed ID: 32241534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure.
    Orban M; Besler C; Braun D; Nabauer M; Zimmer M; Orban M; Noack T; Mehilli J; Hagl C; Seeburger J; Borger M; Linke A; Thiele H; Massberg S; Ender J; Lurz P; Hausleiter J
    Eur J Heart Fail; 2018 Jun; 20(6):1055-1062. PubMed ID: 29405554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitraclip procedure as a bridge therapy in a patient with heart failure listed for heart transplantation.
    Garatti A; Castelvecchio S; Bandera F; Medda M; Menicanti L
    Ann Thorac Surg; 2015 May; 99(5):1796-9. PubMed ID: 25952210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.
    Gyoten T; Messroghli D; Schenk S; Rochor K; Grimmig O; Just S; Fritzsche D
    Open Heart; 2020; 7(1):e001203. PubMed ID: 32201589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Mitral Transcatheter Edge-to-Edge Repair for Recurrent Significant Mitral Regurgitation.
    Shechter A; Lee M; Kaewkes D; Koren O; Skaf S; Chakravarty T; Koseki K; Patel V; Makkar RR; Siegel RJ
    J Am Heart Assoc; 2023 May; 12(9):e028654. PubMed ID: 37119061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system.
    Wengenmayer T; Zehender M; Bothe W; Bode C; Grundmann S
    EuroIntervention; 2016 Apr; 11(13):1541-4. PubMed ID: 27107316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MitraClip
    Vasquez-Rodríguez JF; Medina HM; Cabrales JR; Torres AG
    Eur Heart J Case Rep; 2020 Feb; 4(1):1-5. PubMed ID: 32467867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter edge-to-edge repair for tricuspid valve regurgitation in apolipoprotein A-I-associated cardiac amyloidosis: case report.
    Alomari M; Reddy P; El Sabbagh A; Pollak P; Lyle M
    Eur Heart J Case Rep; 2023 Dec; 7(12):ytad582. PubMed ID: 38130865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction.
    Kresoja KP; Lauten A; Orban M; Rommel KP; Alushi B; Besler C; Braun D; Unterhuber M; Stangl K; Landmesser U; Massberg S; Thiele H; Hausleiter J; Lurz P
    Eur J Heart Fail; 2020 Oct; 22(10):1817-1825. PubMed ID: 32741057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.
    Gerges F; Komaranchath A; Al Bakshy F; Almaghraby A
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa530. PubMed ID: 33738400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous interventions for mitral and tricuspid heart valve diseases.
    Tabata N; Sugiura A; Tsujita K; Nickenig G; Sinning JM
    Cardiovasc Interv Ther; 2020 Jan; 35(1):62-71. PubMed ID: 31396890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical revision after percutaneous mitral valve repair by edge-to-edge device: when the strategy fails in the highest risk surgical population.
    Alozie A; Westphal B; Kische S; Kaminski A; Paranskaya L; Bozdag-Turan I; Ortak J; Schubert J; Steinhoff G; Ince H
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):55-60. PubMed ID: 24321993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Transcatheter valve repair with Cardioband: a new treatment option for secondary tricuspid regurgitation in cardiac transplant patients.
    Wösten M; Baldus S; Pfister R
    Eur Heart J Case Rep; 2020 Dec; 4(6):1-4. PubMed ID: 33447726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.